uniQure N.V. (QURE) vs Syndax Pharmaceuticals, Inc. (SNDX)
A side-by-side comparison of uniQure N.V. and Syndax Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
QURE
uniQure N.V.
$21.90HealthcareDelayed quote: Oct 6, 2026, 1:30 PM EDT
SNDX
Syndax Pharmaceuticals, Inc.
$17.33HealthcareDelayed quote: Oct 6, 2026, 1:30 PM EDT
Total return — QURE vs SNDX
growth of $100 · dividends reinvested · last 10yQURE +188.2% (+11.2%/yr)SNDX +13.6% (+1.3%/yr)QURE compounded faster over this window
QURE SNDX
QURE vs SNDX: by the numbers
- •SNDX is the larger company ($1.54B vs $1.52B market cap).
- •Both run net losses; SNDX's is the smaller (-87.60% vs -1350.73% net margin).
- •SNDX grew revenue faster over the past five years (178.06% vs -48.20% CAGR).
Metrics side by side
Valuation
| Metric | QURE | SNDX |
|---|---|---|
| P/S ratio | 81.36 | 6.09 |
| P/B ratio | 4.69 | 101.70 |
Profitability
| Metric | QURE | SNDX |
|---|---|---|
| Gross margin | 89.53% | 97.47% |
| Operating margin | -1166.77% | -158.45% |
| Net margin | -1350.73% | -87.60% |
| ROE | -77.83% | -1462.12% |
| ROIC | -22.55% | -32.15% |
Growth (annualized)
| Metric | QURE | SNDX |
|---|---|---|
| Revenue CAGR (5Y) | -48.20% | 178.06% |
| Total return CAGR (5Y) | -6.16% | -0.01% |
Frequently asked
- Which has grown faster, QURE or SNDX?
- Over the past five years, SNDX grew revenue faster — QURE at a -48.20% CAGR versus SNDX at 178.06%.
- How have QURE and SNDX total returns compared?
- Over the past 10 years, QURE delivered 11.17% and SNDX delivered 1.04% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
uniQure ROESyndax Pharmaceuticals ROEuniQure operating marginSyndax Pharmaceuticals operating marginuniQure revenue growthSyndax Pharmaceuticals revenue growthuniQure free cash flowSyndax Pharmaceuticals free cash flow
uniQure & Syndax Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.